Literature DB >> 7682177

The human granulocyte-macrophage colony-stimulating factor receptor is capable of initiating signal transduction in NIH3T3 cells.

M Eder1, J D Griffin, T J Ernst.   

Abstract

The ability of the receptor for the hematopoietic cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) to function in non-hematopoietic cells is unknown. NIH3T3 fibroblasts were transfected with cDNAs encoding the alpha and beta subunit of the human GM-CSF receptor and a series of stable transformants were isolated that bound GM-CSF with either low (KD = 860 - > 1000 pM) or high affinity (KD = 20-80 pM). Low affinity receptors were not functional. However, the reconstituted high affinity receptors were found to be capable of activating a number of signal transduction pathways, including tyrosine kinase activity, phosphorylation of Raf-1, and the transient induction of c-fos and c-myc mRNAs. The activation of protein tyrosine phosphorylation by GM-CSF in NIH3T3 cells was rapid (< 1 min) and transient (peaking at 5-20 min) and resulted in the phosphorylation of proteins of estimated molecular weights of 42, 44, 52/53 and 58-60 kDa. Some of these proteins co-migrated with proteins from myeloid cells that were phosphorylated on tyrosine residues in response to GM-CSF. In particular, p42 and p44 were identified as mitogen-activated protein kinases (MAP kinases), and the phosphorylation on tyrosine residues of p42 and p44 MAP kinases occurred at the same time as the phosphorylation of Raf-1. However, despite evidence for activation of many mitogenic signal transduction molecules, GM-CSF did not induce significant proliferation of transfected NIH3T3 cells. These results suggest that murine fibroblasts contain signal transducing molecules that can effectively interact with the human GM-CSF receptor, and that are sufficient to activate at least some of the same signal transduction pathways this receptor activates in myeloid cells, including activation of one or more tyrosine kinase(s). However, the level of activation of signal transduction is either below a threshold of necessary activity or at least one mitogenic signal necessary for proliferation is missing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682177      PMCID: PMC413379          DOI: 10.1002/j.1460-2075.1993.tb05810.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 2.  Regulation of the production and function of granulocytes and monocytes.

Authors:  S A Cannistra; J D Griffin
Journal:  Semin Hematol       Date:  1988-07       Impact factor: 3.851

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  Molecular control of granulocyte and macrophage production.

Authors:  D Metcalf
Journal:  Prog Clin Biol Res       Date:  1985

Review 5.  The molecular control of blood cell development.

Authors:  L Sachs
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

8.  Assay of transforming activity of tumor virus DNA.

Authors:  A J van der Eb; F L Graham
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

Authors:  M F Roussel; T J Dull; C W Rettenmier; P Ralph; A Ullrich; C J Sherr
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

10.  Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells.

Authors:  J H Pierce; M Ruggiero; T P Fleming; P P Di Fiore; J S Greenberger; L Varticovski; J Schlessinger; G Rovera; S A Aaronson
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

View more
  6 in total

1.  Dose-dependent impairment of collagen deposition by topical granulocyte-macrophage colony-stimulating factor in human experimental wounds.

Authors:  Lars N Jorgensen; Magnus S Agren; Søren M Madsen; Finn Kallehave; Faranak Vossoughi; Annette Rasmussen; Finn Gottrup
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  Differential regulation of early response genes and cell proliferation through the human granulocyte macrophage colony-stimulating factor receptor: selective activation of the c-fos promoter by genistein.

Authors:  S Watanabe; A Muto; T Yokota; A Miyajima; K Arai
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

3.  CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

Authors:  R K Ganju; M Sunday; D G Tsarwhas; A Card; M A Shipp
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway.

Authors:  D X Ding; C I Rivas; M L Heaney; M A Raines; J C Vera; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

5.  Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor beta-chain involving tyrosine-750.

Authors:  R C Inhorn; N Carlesso; M Durstin; D A Frank; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.

Authors:  D Rajotte; C Cadieux; A Haman; B C Wilkes; S C Clark; T Hercus; J A Woodcock; A Lopez; T Hoang
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.